Vosevi(Sofosbuvir/Velpatasvir/Voxilaprevir) Side Effects

A description of the most common and serious adverse reactions associated with the drug.

Adverse Reactions

The most common adverse reactions (occurring in ≥10% of patients) during 12 weeks of treatment with VOSEVI were headache, fatigue, diarrhea, and nausea. Most of these events were mild to moderate in severity. Serious adverse reactions include the risk of hepatitis B virus (HBV) reactivation in coinfected patients, hepatic decompensation in patients with advanced liver disease, and serious symptomatic bradycardia when coadministered with amiodarone.

Sofosbuvir/Velpatasvir/Voxilaprevir(Vosevi)
Treatment of chronic HCV infection in adults without cirrhosis or with compensated cirrhosis who have prior treatment experience with specific HCV regimens.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved